洁特生物(688026) - 2025 Q4 - 年度业绩

Financial Performance - The company achieved total revenue of RMB 55,700.74 million in 2024, representing a year-on-year increase of 20.28%[4] - Operating profit reached RMB 9,733.00 million, up 146.76% compared to the previous year[4] - Net profit attributable to the parent company was RMB 7,381.42 million, reflecting a growth of 112.18% year-on-year[4] - The basic earnings per share increased to RMB 0.53, a rise of 112.00% from the previous year[4] Asset Management - The company's total assets at the end of 2024 were RMB 170,580.67 million, a 4.90% increase from the beginning of the period[4] Profitability - The gross profit margin improved by 10.1 percentage points to 40.7% due to cost optimization and increased sales volume[11] Product Development - The company developed several new products, including storage bags and cell culture bags, enhancing its product portfolio[9] Brand Promotion - The company participated in over 30 domestic and international life science and biotechnology exhibitions, boosting brand exposure[10] - The company plans to continue expanding its international brand promotion in regions such as Europe, the Middle East, and Southeast Asia[11] Market Environment - The company is benefiting from favorable policies in the domestic market, particularly in the life sciences sector, which is experiencing a recovery[9]